Support for Behavioral Modification in Modern Obesity Management
-
By
-
Brunna Boaventura
-
Stuart W Flint
-
August 28, 2026
By
Brunna Boaventura
Stuart W Flint
August 28, 2026
by Brunna Boaventura, Stuart W Flint
August 28, 2026
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
July 16, 2026